Fig. 3From: First preclinical evaluation of [225Ac]Ac-DOTA-JR11 and comparison with [177Lu]Lu-DOTA-JR11, alpha versus beta radionuclide therapy of NETsAutoradiography acquisition of A a tumor slice and B left and right kidneys slice. Tissues were harvested from a mouse 24 h after injection of 23.4 ± 1.5 kBq/0.5 nmol of [225Ac]Ac-DOTA-JR11Back to article page